Alkhilaiwi, Faris <br/><br/>
High-throughput screening identifies candidate drugs for the treatment of recurrent respiratory papillomatosis.  [electronic resource] 

 -  Papillomavirus research (Amsterdam, Netherlands)  12 2019 
 - 100181 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2405-8521 
<br/><br/><label>Standard No.: </label>10.1016/j.pvr.2019.100181  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Biopsy<br/>Cell Culture Techniques<br/>Cell Line<br/>Cell Survival--drug effects<br/>Disease Models, Animal<br/>Disease Susceptibility<br/>Dose-Response Relationship, Drug<br/>Drug Discovery--methods<br/>High-Throughput Screening Assays--methods<br/>Human papillomavirus 6--physiology<br/>Humans<br/>Mice<br/>Microbial Sensitivity Tests<br/>Papillomavirus Infections--complications<br/>Respiratory Tract Infections--drug therapy